Elder Dr Samuel Amo Tobbin, Group Chairman of Tobinco Pharmaceuticals Limited (TPL), has attributed his vindication in his longstanding legal dispute with the Food and Drugs Authority (FDA), to his practice of paying tithes. The controversy dates back to September and December 2013, when Dr Kwabena Opuni, then Chief Executive Officer (CEO) of the FDA, initiated a series of actions against TPL. These actions were based on allegations that the company had imported counterfeit drugs into the country. As part of these measures, the FDA locked Tobinco's warehouses nationwide, causing significant embarrassment for the company and its chairman. The regulator also disposed of Tobinco's products, resulting in substantial financial losses as the products expired rapidly.